Allogeneic T cells: maestro in the co-ordination of the immune response after hematopoietic stem cell transplantation.
作者信息
Saudemont Aurore, Madrigal J Alejandro
出版信息
Haematologica. 2014 Feb;99(2):203-5. doi: 10.3324/haematol.2013.101295.
Abstract
摘要
相似文献
1
Allogeneic T cells: maestro in the co-ordination of the immune response after hematopoietic stem cell transplantation.
Haematologica. 2014 Feb;99(2):203-5. doi: 10.3324/haematol.2013.101295.
2
Development of a coordinated allo T cell and auto B cell response against autosomal PTK2B after allogeneic hematopoietic stem cell transplantation.
Haematologica. 2014 Feb;99(2):365-9. doi: 10.3324/haematol.2013.086652. Epub 2013 Oct 4.
3
Identification of 4 new HLA-DR-restricted minor histocompatibility antigens as hematopoietic targets in antitumor immunity.
Blood. 2009 Oct 22;114(17):3684-92. doi: 10.1182/blood-2009-03-208017. Epub 2009 Aug 25.
4
Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritis.
Exp Hematol. 2000 Jul;28(7):853-7. doi: 10.1016/s0301-472x(00)00172-7.
5
Different immune reconstitution in multiple myeloma, chronic myeloid leukemia and acute myeloid leukemia patients after allogeneic transplantation of peripheral blood stem cells.
Bone Marrow Transplant. 2000 Dec;26(12):1325-31. doi: 10.1038/sj.bmt.1702709.
6
Effector memory CD4+ T cells mediate graft-versus-leukemia without inducing graft-versus-host disease.
Blood. 2008 Feb 15;111(4):2476-84. doi: 10.1182/blood-2007-08-109678. Epub 2007 Nov 28.
7
Allogeneic hematopoietic stem cell transplantation recipients have defects of both switched and igm memory B cells.
Biol Blood Marrow Transplant. 2009 Jul;15(7):795-803. doi: 10.1016/j.bbmt.2008.11.024.
8
[Advances in Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia--Review].
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2019 Aug;27(4):1334-1338. doi: 10.19746/j.cnki.issn.1009-2137.2019.04.057.
9
Association with the presence of naive T cells in chronic myeloid leukemia patients after allogeneic human stem cell transplantation and the lower incidence of chronic graft-versus host disease and relapse.
Transplant Proc. 2007 Nov;39(9):2898-901. doi: 10.1016/j.transproceed.2007.08.036.
10
Donor T cells administered over HLA class II barriers mediate antitumor immunity without broad off-target toxicity in a NOD/scid mouse model of acute leukemia.
Biol Blood Marrow Transplant. 2013 Jun;19(6):867-75. doi: 10.1016/j.bbmt.2013.03.003. Epub 2013 Mar 13.
引用本文的文献
1
Early and Late Complications in Patients with Allogeneic Transplantation of Hematopoietic Stem Cell - Case Report.
Open Access Maced J Med Sci. 2017 May 9;5(3):340-343. doi: 10.3889/oamjms.2017.038. eCollection 2017 Jun 15.
本文引用的文献
1
Development of a coordinated allo T cell and auto B cell response against autosomal PTK2B after allogeneic hematopoietic stem cell transplantation.
Haematologica. 2014 Feb;99(2):365-9. doi: 10.3324/haematol.2013.086652. Epub 2013 Oct 4.
2
Combined CD4 T-cell and antibody response to human minor histocompatibility antigen DBY after allogeneic stem-cell transplantation.
Transplantation. 2011 Aug 15;92(3):359-65. doi: 10.1097/TP.0b013e3182244cc3.
3
Identification of 4 new HLA-DR-restricted minor histocompatibility antigens as hematopoietic targets in antitumor immunity.
Blood. 2009 Oct 22;114(17):3684-92. doi: 10.1182/blood-2009-03-208017. Epub 2009 Aug 25.
4
Allogeneic disparities in immunoglobulin-like transcript 5 induce potent antibody responses in hematopoietic stem cell transplant recipients.
Blood. 2009 Sep 10;114(11):2323-32. doi: 10.1182/blood-2008-10-183814. Epub 2009 Jul 17.
5
Identification of phosphatidylinositol 4-kinase type II beta as HLA class II-restricted target in graft versus leukemia reactivity.
Proc Natl Acad Sci U S A. 2008 Mar 11;105(10):3837-42. doi: 10.1073/pnas.0712250105. Epub 2008 Mar 3.
6
Hematopoietic stem-cell transplantation.
N Engl J Med. 2006 Apr 27;354(17):1813-26. doi: 10.1056/NEJMra052638.
7
Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission.
Blood. 2005 Apr 1;105(7):2973-8. doi: 10.1182/blood-2004-09-3660. Epub 2004 Dec 21.
8
Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantation.
J Exp Med. 2004 Apr 19;199(8):1133-42. doi: 10.1084/jem.20031560.
9
Detection of a potent humoral response associated with immune-induced remission of chronic myelogenous leukemia.
J Clin Invest. 2000 Sep;106(5):705-14. doi: 10.1172/JCI10196.
10
Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients.
Blood. 1990 Dec 15;76(12):2462-5.
Zotero 插件